MANUFACTURERS LIFE INSURANCE COMPANY, THE - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$224,785
+23.2%
12,941
-0.1%
0.00%
Q2 2023$182,392
+36.6%
12,954
+4.4%
0.00%
Q1 2023$133,553
-28.2%
12,4120.0%0.00%
Q4 2022$185,932
+6.8%
12,412
-8.5%
0.00%
Q3 2022$174,162
+29.2%
13,564
-2.5%
0.00%
Q2 2022$134,788
-3.1%
13,910
-0.6%
0.00%
Q1 2022$139,140
-30.1%
13,998
-17.3%
0.00%
Q4 2021$199,000
-1.5%
16,931
-4.5%
0.00%
Q3 2021$202,000
-22.0%
17,725
-4.8%
0.00%
Q2 2021$259,000
-17.8%
18,623
+9.4%
0.00%
Q1 2021$315,000
+5.0%
17,016
+0.4%
0.00%
Q4 2020$300,000
+25.5%
16,950
+8.5%
0.00%
Q3 2020$239,000
-24.6%
15,621
+27.9%
0.00%
Q2 2020$317,000
+103.2%
12,209
+21.0%
0.00%
Q1 2020$156,000
+69.6%
10,088
-4.1%
0.00%
Q3 2019$92,000
-34.8%
10,514
+1.3%
0.00%
Q2 2019$141,00010,3810.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders